| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Nuvo Pharmaceuticals Inc (OTCQX: MRVFF)
MRVFF Technical Analysis
2
| As on 16th Mar 2023 MRVFF STOCK Price closed @ 0.98 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.95 & Strong Sell for SHORT-TERM with Stoploss of 1.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MRVFFSTOCK Price
| Open | 0.98 | Change | Price | % |
| High | 0.98 | 1 Day | 0.00 | 0.00 |
| Low | 0.98 | 1 Week | 0.00 | 0.00 |
| Close | 0.98 | 1 Month | 0.01 | 1.03 |
| Volume | N/A | 1 Year | -0.07 | -6.67 |
| 52 Week High 1.39 | 52 Week Low 0.42 | ||||
OTCQX USA Most Active Stocks
| KRRGF | 4.83 | 2.33% |
| FCUUF | 0.52 | -20.00% |
| ETHE | 27.50 | -3.34% |
| ZNOG | 0.16 | 6.67% |
| GBTC | 79.98 | 5.38% |
| EMHTF | 0.04 | 33.33% |
| SHIEF | 0.04 | 0.00% |
| GTBIF | 8.95 | 14.74% |
| FNGR | 3.22 | 1.90% |
| BABYF | 0.02 | -33.33% |
OTCQX USA Top Gainers Stocks
OTCQX USA Top Losers Stocks
| MRVFF Daily Charts |
MRVFF Intraday Charts |
Whats New @ Bazaartrend |
MRVFF Free Analysis |
|
|
MRVFF Important Levels Intraday
| RESISTANCE | 0.98 |
| RESISTANCE | 0.98 |
| RESISTANCE | 0.98 |
| RESISTANCE | 0.98 |
| RESISTANCE | 0.98 |
| RESISTANCE | 0.98 |
| RESISTANCE | 0.98 |
| RESISTANCE | 0.98 |
MRVFF Forecast May 2025
| 4th UP Forecast | 1.54 |
| 3rd UP Forecast | 1.36 |
| 2nd UP Forecast | 1.25 |
| 1st UP Forecast | 1.14 |
| 1st DOWN Forecast | 0.82 |
| 2nd DOWN Forecast | 0.71 |
| 3rd DOWN Forecast | 0.6 |
| 4th DOWN Forecast | 0.42 |
MRVFF Weekly Forecast
| 4th UP Forecast | 1.13 |
| 3rd UP Forecast | 1.08 |
| 2nd UP Forecast | 1.05 |
| 1st UP Forecast | 1.02 |
| 1st DOWN Forecast | 0.94 |
| 2nd DOWN Forecast | 0.91 |
| 3rd DOWN Forecast | 0.88 |
| 4th DOWN Forecast | 0.83 |
MRVFF Forecast2025
| 4th UP Forecast | 2.89 |
| 3rd UP Forecast | 2.28 |
| 2nd UP Forecast | 1.9 |
| 1st UP Forecast | 1.52 |
| 1st DOWN Forecast | 0.44 |
| 2nd DOWN Forecast | 0.06 |
| 3rd DOWN Forecast | -0.32 |
| 4th DOWN Forecast | -0.93 |
Nuvo Pharmaceuticals Inc ( OTCQX USA Symbol : MRVFF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MRVFF Business Profile
Nuvo Pharmaceuticals Inc. provides prescription and non-prescription products for pain, allergy, neurology, and dermatology worldwide. The company operates in three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. It offers Blexten, an antihistamine drug for the symptomatic relief of allergic rhinitis and chronic spontaneous urticarial; Cambia, a nonsteroidal anti-inflammatory drug for migraine; Suvexx/Treximet migraine medicine; NeoVisc viscosupplement for knee osteoarthritis; and Resultz/FullMarks/LAUSBUB for head lice infestations. The company also provides Bezalip SR for patients with high cholesterol or high levels of triglycerides; Proferrin, an iron supplement for the prevention and treatment of iron deficiency; Fiorinal 1 and Fiorinal C1 for the relief of tension-type headaches; Viskazide and Visken antihypertensive agents; Collatamp G for surgical implantation during surgery; PegaLAX, a laxative for the treatment of occasional constipation and irregularity; Mutaflor, a probiotic for the management and relief of chronic constipation and associated abdominal pain and cramps; MoviPrep for the cleansing of the colon in preparation for colonoscopy; Uracyst for mild to severe GAG layer damage of the urinary bladder; and Soriatane to treat psoriasis and other keratinization disorders. In addition, it offers Pennsaid and Pennsaid 2% topical treatments for osteoarthritic pain; Vimovo for relief of arthritis symptoms; SYNERA/RAPYDAN topical patches used to help prevent pain associated with needle sticks and other superficial skin procedures; Yosprala for the prevention of heart attacks and strokes; and Heated Lidocaine/Tetracaine Patch, a topical patch applied prior to painful medical procedures. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada. Address: 6733 Mississauga Road, Mississauga, ON, Canada, L5N 6J5
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service